## Abstract The aim of this article was to evaluate cancer occurrence before and after diagnosis of Parkinson's disease (PD). We investigated 692 patients newly diagnosed with PD and 761 age‐ and sex‐matched control subjects identified during two periods (1994–1995 and 2000–2003) within Kaiser Perm
Assessing comorbidity in patients with Parkinson's disease
✍ Scribed by Martine Visser; Johan Marinus; Jacobus J. van Hilten; Ruth G.B. Schipper; Anne M. Stiggelbout
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 229 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The aim of this study was to assess the accuracy of an interview‐based assessment of comorbidity, in patients with Parkinson's disease (PD). The Cumulative Illness Rating Scale‐Geriatric (CIRS‐G) was completed (1) in an interview with 31 PD patients and their caregivers, and (2) by reviewing the patient's medical charts from their general practitioners. Based on the interview, all patients had some comorbidity, 84% had one or more moderate comorbid diseases. The most frequently affected organ systems were “lower gastrointestinal” and “genitourinary”. The mean ± SD total score of the interview‐based (chart‐based) CIRS‐G was 6.9 ± 3.8 (7.6 ± 3.5) with a mean of 4.3 ± 1.9 (5.0 ± 1.9) affected organ systems and a mean of 2.1 ± 1.7 (2.3 ± 1.6) organ systems with at least moderate comorbidity per patient. The agreement (intraclass correlation coefficients) between the interview‐based and chart‐based assessments for the six summary scores ranged from 0.69 to 0.81. The agreement for the 14 organ systems ranged from 0.13 to 1.00 (weighted kappa); 12 had a K~w~ above 0.40 (moderate agreement). The comorbidity summary scores had a moderate correlation with age and disability. The interview‐based assessment of the CIRS‐G is easy to apply and is an accurate method to assess comorbidity in patients with PD. © 2004 Movement Disorder Society
📜 SIMILAR VOLUMES
Parkinson's disease (PD) is a disabling neurodegenerative condition commonly complicated by the existence of comorbid depression. The prevalence rates of depression in this patient group have been reported to be as high as 40%. Currently, depression in PD is undertreated; there have been few control
## Objective: To compare the prevalence of fatigue in patients with parkinson's disease (pd) with that in healthy elderly people and to explore the suggestion that fatigue is an independent symptom of pd. ## Design: Questionnaire survey. ## Setting: Community-based population. ## Patients and
## Abstract Impulsivity may be induced by therapeutic interventions (dopamine replacement therapies and sub‐thalamic nucleus (STN) stimulation) in patients with Parkinson's disease (PD). The present review has two goals. First, to describe the most frequently encountered facets of cognitive impulsi
## Abstract Mirror movements (MM) refer to ipsilateral involuntary movements that appear during voluntary activity in contralateral homologous body regions. This study aimed to compare the frequency and distribution of MM in an unselected sample of 274 patients with Parkinson's disease (PD) and 100